Lark Health Raises $100M Series D Funding

Oct. 13, 2021 /PRNewswire/ — FLG Client Lark Health today announced that it has closed a $100 million Series D funding round led by Deerfield Management Company. The funding round also includes crossover fund PFM Health Sciences, as well as returning investors Franklin Templeton, King River Capital, Castlepeak, IPD, Olive Tree Capital, and Marvell…Read More

Read More
Zum Raises $130M Series D to Accelerate Plan To Modernize School Transportation

October 7, 2021 – FLG client Zum, a leader revolutionizing school transportation, announced their Series D $130M fundraise led by Softbank Vision Fund 2, with participation from existing investors, including Sequoia and BMW i Ventures. FLG’s Chris Cook assisted the team at Zum with planning and closing the transaction. Read…Read More

Read More
Trove Secures $77.5 Million Series D Funding Round

August 25, 2021 – FLG Partner’s client Trove, the market leader in branded resale commerce for lululemon, Patagonia, REI, Nordstrom, Levi’s, Eileen Fisher, Arc’teryx and other leading brands, today announced that it has closed a $77.5 million Series D funding round led by G2 Venture Partners, bringing Trove’s total funding…Read More

Read More
Elevation Oncology Announces Its Initial Public Offering

June 24, 2021 – Elevation Oncology, Inc. (NASDAQ: ELEV) today announced its initial public offering at $16.00 per share. Company press release. FLG partner: Eric Hall.

Read More
Vera Therapeutics Announces its Initial Public Offering

May 13, 2021 – Today Vera Therapeutics announced the pricing of its IPO at $11.00 per share. Company Press release. FLG partner: Jonathan Wolter.

Read More